{ "guide": { "slug": "dissolvd-rebuild-bpc-157", "title": "Dissolvd Rebuild BPC-157 Guide", "subtitle": "A safety-first guide to Dissolvd Rebuild, an oral dissolving strip that lists 500 mcg BPC-157 per serving.", "summary": "Dissolvd Rebuild is marketed as a BPC-157 oral strip for recovery, structural support, gut health, and inflammation balance. The product page supports the label facts, but independent public sources make the core decision conservative: BPC-157 remains an unapproved experimental peptide with limited human safety and efficacy evidence.", "category": { "slug": "health-nutrition", "name": "Health & Nutrition", "description": "Evidence-graded guides for nutrition, supplements, personal health decisions, and practical risk tradeoffs." }, "tags": [ "bpc-157", "dissolvd", "peptides", "recovery", "supplements", "anti-doping", "safety" ], "archetype": "health", "version": "2026-06-26.1", "publishedAt": "2026-06-26", "updatedAt": "2026-06-26", "freshness": "Checked on 2026-06-26 against the Dissolvd Rebuild product page, FDA safety-risk language current as of 2026-04-22, USADA anti-doping guidance, OPSS guidance, PubMed review context, and ClinicalTrials.gov search results. Re-check regulatory status before acting.", "heroLabel": "BPC-157 strip", "vaultPath": "Research/Health/Dissolvd Rebuild BPC-157 Guide.md", "r2JsonKey": "guides/dissolvd-rebuild-bpc-157/2026-06-26.1.json", "thesisCards": [ { "label": "Product fact", "title": "The label says 500 mcg BPC-157 per strip.", "body": "Dissolvd Rebuild is a daily oral dissolving strip marketed for recovery, gut health, mobility, and structural support." }, { "label": "Evidence gap", "title": "The product format is more confident than the human evidence.", "body": "Public human evidence for BPC-157 remains thin, and the route-specific safety and efficacy case is not established." }, { "label": "Rule", "title": "Avoid treating this as a normal wellness supplement.", "body": "Tested athletes, service members, and people managing injuries or medical symptoms should treat BPC-157 as an avoid-or-medical-oversight topic." } ], "stats": [ { "label": "Listed dose", "value": "500 mcg", "detail": "Dissolvd lists BPC-157 at 500 mcg per serving." }, { "label": "Label use", "value": "daily", "detail": "The product page says to take one strip daily." }, { "label": "Reviews", "value": "0", "detail": "The page showed no customer rating and no matching reviews when checked." }, { "label": "Athletes", "value": "avoid", "detail": "USADA identifies BPC-157 as prohibited under WADA S0." } ], "sections": [ { "id": "bottom-line", "eyebrow": "Bottom line", "title": "The useful guide is mostly about why not to self-direct it.", "body": "Dissolvd Rebuild has a clear product page and convenient strip format. That does not solve the bigger BPC-157 problem: no approved human-use indication, limited safety data, uncertain route/formulation evidence, and explicit anti-doping boundaries. This guide is informational and is not medical advice." }, { "id": "product-label", "eyebrow": "Label", "title": "What Dissolvd actually lists.", "table": { "columns": [ "Field", "Product-page claim", "Decision note" ], "rows": [ [ "Ingredient", "BPC-157, 500 mcg per serving.", "This is a label fact, not proof of efficacy." ], [ "Format", "Oral dissolving strip that dissolves in 30-45 seconds.", "Convenience does not establish superior absorption or outcomes." ], [ "Use direction", "One strip daily, morning or post-activity.", "Do not treat vendor directions as an evidence-based medical protocol." ], [ "Review signal", "No customer rating and zero displayed reviews at check time.", "There is no product-specific user-signal base to synthesize." ] ] } }, { "id": "who-should-avoid", "eyebrow": "Avoid", "title": "Most high-stakes readers should not use it casually.", "table": { "columns": [ "Reader", "Recommendation", "Reason" ], "rows": [ [ "Tested athlete", "Avoid.", "BPC-157 is prohibited under WADA S0 unapproved substances." ], [ "Service member", "Avoid unless cleared through official medical and supplement channels.", "OPSS warns against BPC-157 in wellness products." ], [ "Injury, surgery, chronic pain, or gut symptoms", "Use diagnosis and clinician-guided care first.", "Self-directed BPC-157 can delay proper treatment." ], [ "Healthy curiosity buyer", "The risk/reward case is weak.", "The evidence gap is larger than the convenience benefit." ] ] } }, { "id": "evidence-boundary", "eyebrow": "Evidence", "title": "BPC-157 has research interest, not a validated consumer protocol.", "table": { "columns": [ "Claim area", "Public evidence read", "Caveat" ], "rows": [ [ "Recovery and tissue support", "Preclinical and small human reports create hypotheses.", "They do not validate a consumer strip for injury recovery." ], [ "Gut support", "BPC-157 has gastric/body-protection-compound research roots.", "Marketing does not equal an approved GI therapy." ], [ "Inflammation balance", "Mechanistic claims are common.", "No broad disease or pain-treatment claim should be inferred." ], [ "Safety", "FDA flags limited safety information and peptide-quality concerns.", "The unknown side-effect profile is the main side-effect problem." ] ] } }, { "id": "protocol-timeline", "eyebrow": "Protocol", "title": "Report the label, but do not convert it into medical advice.", "table": { "columns": [ "Question", "Answer", "Why" ], "rows": [ [ "What is the protocol?", "The product label says one 500 mcg strip daily.", "That is a vendor direction, not a validated human protocol." ], [ "How long until results?", "No reliable timeline can be promised.", "The public human evidence does not establish this strip's effect timing." ], [ "What side effects?", "Unknown safety, impurity, immune response, and delayed-care risks matter most.", "The issue is insufficient safety information, not a tidy known side-effect list." ], [ "What goes well with it?", "A diagnosis-first recovery plan, not a peptide stack.", "Stacking experimental products makes attribution and safety worse." ] ] } }, { "id": "alternatives", "eyebrow": "Alternatives", "title": "Use boring, higher-evidence recovery moves first.", "table": { "columns": [ "Goal", "Better first move", "Why" ], "rows": [ [ "Training recovery", "Sleep, nutrition, load management, protein, and creatine if appropriate.", "These have better practical evidence and lower regulatory ambiguity." ], [ "Injury rehab", "Physical therapy and diagnosis.", "A peptide strip should not replace tissue-specific care." ], [ "Joint pain", "Condition-specific care, strength work, and evidence-backed joint supplements only if appropriate.", "Pain is a symptom to evaluate, not a supplement target by default." ], [ "Gut symptoms", "Medical evaluation and standard GI care.", "Persistent GI symptoms need diagnosis." ] ] } } ], "sources": [ { "id": "dissolvd-rebuild", "title": "Rebuild product page", "url": "https://www.dissolvdstrips.com/product/rebuild/", "publisher": "Dissolvd", "accessedAt": "2026-06-26", "sourceType": "official" }, { "id": "fda-bpc-157", "title": "Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks", "url": "https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks", "publisher": "FDA", "accessedAt": "2026-06-26", "sourceType": "official" }, { "id": "usada-bpc-157", "title": "BPC-157: Experimental Peptide Prohibited", "url": "https://www.usada.org/spirit-of-sport/bpc-157-peptide-prohibited/", "publisher": "USADA", "accessedAt": "2026-06-26", "sourceType": "official" }, { "id": "opss-bpc-157", "title": "BPC-157: A prohibited peptide and an unapproved drug found in health and wellness products", "url": "https://www.opss.org/article/bpc-157-prohibited-peptide-and-unapproved-drug-found-health-and-wellness-products", "publisher": "OPSS", "accessedAt": "2026-06-26", "sourceType": "official" } ], "claims": [ { "id": "rebuild-label-dose", "claim": "Dissolvd Rebuild lists BPC-157 at 500 mcg per serving and instructs one strip daily.", "sourceId": "dissolvd-rebuild", "evidenceType": "official", "confidence": "high", "caveat": "Product pages can change and label facts are not efficacy evidence.", "guideLocation": "Label", "sectionId": "product-label" }, { "id": "fda-bpc-157-safety-risk", "claim": "FDA has identified limited safety information and peptide impurity/API characterization concerns for BPC-157.", "sourceId": "fda-bpc-157", "evidenceType": "official", "confidence": "high", "caveat": "Regulatory status may evolve after advisory meetings or policy updates.", "guideLocation": "Evidence", "sectionId": "evidence-boundary" }, { "id": "usada-bpc-157-prohibited", "claim": "USADA identifies BPC-157 as prohibited under WADA S0 unapproved substances.", "sourceId": "usada-bpc-157", "evidenceType": "official", "confidence": "high", "caveat": "Athletes should still check current Global DRO and governing-body rules.", "guideLocation": "Avoid", "sectionId": "who-should-avoid" } ] }, "publicUrl": "https://fieldguides.co/g/dissolvd-rebuild-bpc-157" }